STALEY CAPITAL ADVISERS’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.9K | Hold |
|
|||||
|
2025
Q1 | $81.3K | Buy |
|
|||||
|
2024
Q4 | $122K | Hold |
|
|||||
|
2024
Q3 | $68.6K | Hold |
|
|||||
|
2024
Q2 | $71.8K | Hold |
|
|||||
|
2024
Q1 | $112K | Hold |
|
|||||
|
2023
Q4 | $85K | Buy |
|
|||||
|
2023
Q3 | $94.8K | Hold |
|
|||||
|
2023
Q2 | $96.2K | Hold |
|
|||||
|
2023
Q1 | $72K | Buy |
|
|||||
|
2022
Q4 | $9K | Hold |
|
|||||
|
2022
Q3 | $14K | Hold |
|
|||||
|
2022
Q2 | $24K | Hold |
|
|||||
|
2022
Q1 | $41K | Hold |
|
|||||
|
2021
Q4 | $64K | Buy |
|
|||||
|
2021
Q3 | $70K | Buy |
|
|||||
|
2021
Q2 | $132K | Buy |
|
|||||
|
2021
Q1 | $171K | Buy |
|
|||||
|
2020
Q4 | $79K | Buy |
|